Beam Therapeutics BEAM Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's deferred tax assets and other non-current assets?
- Beam Therapeutics (BEAM) reported deferred tax assets and other non-current assets of $7.76M in Q1 2026.
- How has Beam Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- Beam Therapeutics's deferred tax assets and other non-current assets increased by 751.5% year-over-year, from $911K to $7.76M.
- What is the long-term trend for Beam Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Beam Therapeutics's deferred tax assets and other non-current assets has grown at a -27.4% compound annual growth rate (CAGR), from $3.14M to $634K.